SPX Corporation
SPXC
$170.62
-2.96%
SPX Technologies, Inc. is a diversified industrial manufacturer operating through two reportable segments: an HVAC segment that designs, manufactures, installs, and services cooling, heating, and ventilation products, and a Detection and Measurement Technologies segment that produces underground pipe and cable locators, inspection equipment, and bus-fare collection systems, with the HVAC segment generating the majority of revenue. The company occupies a niche position as a specialized engineered-products supplier rather than a broad-line industrial conglomerate, deriving maximum revenue from the United States with additional operations in Canada, China, and the United Kingdom. The current investor narrative centers on a sharp divergence between strong fundamental momentum — highlighted by 22.9% year-over-year revenue growth in the most recent quarter and a 40.2% gross margin — and a stock price that has fallen roughly 8% over the past year and nearly 24% over three months, leaving investors to debate whether the selloff represents an attractive entry point or a warning about forward demand. Analyst sentiment remains overwhelmingly constructive, with a strong buy consensus and a 13-analyst average target well above the current price, suggesting the market is pricing in a disconnect that bulls view as a valuation opportunity and bears view as justified caution on cyclical end markets.…
SPXC
SPX Corporation
$170.62
Investment Opinion: Should I buy SPXC Today?
The synthesized recommendation is a Buy, but with above-average risk. The core thesis is that SPX Technologies is fundamentally undervalued relative to its growth trajectory and analyst targets, with a forward PE of 17.84x and a 52.1% upside to the average analyst target of $263.31. The strong buy consensus (1.23 mean rating from 13 analysts) and the disconnect between reported 22.9% revenue growth and the stock's 23.99% three-month decline suggest a sentiment-driven dislocation that long-term investors can exploit.
Supporting evidence includes: 1) Revenue growth of 22.9% YoY in Q2 2026, accelerating from prior quarters; 2) Gross margin of 40.18% and operating margin expansion to 17.17% from 15.68%; 3) Free cash flow of $303.4 million TTM, yielding 3.2%; 4) Forward PE of 17.84x, below the S&P 500 average, with a PEG of 2.24 that is high but justified by growth; and 5) Analyst target upside of 52.1%, with even the low target implying 24.2% upside. The balance sheet is conservative with debt-to-equity of 0.224 and a current ratio of 2.48.
The biggest risks are: 1) Technical breakdown below the 52-week low of $166.17, which could trigger further selling; 2) A deceleration in revenue growth or margin contraction that would invalidate the forward earnings estimates; and 3) Multiple compression if the market continues to de-rate industrial stocks. The rating would upgrade to a Strong Buy if the stock establishes a base above $180 and Q3 earnings confirm continued growth, or downgrade to Hold if revenue growth falls below 15% or if the stock breaks below $166.17 on high volume. Relative to its history, the forward PE is near the low end of its range, suggesting the stock is undervalued on forward earnings, but the trailing PE is near the high end, indicating the market is paying for future growth. Overall, the stock appears undervalued relative to its growth prospects and analyst targets, but the technical weakness warrants caution.
Sign up to view all
SPXC 12-Month Price Forecast
The forward-looking view is cautiously neutral with a bias toward the base case. The company's fundamental momentum is strong, but the market's persistent selling pressure and the stock's position near 52-week lows suggest that either the market is pricing in a significant slowdown or that there are undisclosed risks. The forward PE of 17.84x is attractive if earnings estimates are met, but the PEG of 2.24 indicates that growth is already priced in. The analyst consensus is overwhelmingly bullish, but the stock's technical breakdown cannot be ignored. I would upgrade to bullish if the stock establishes a base above $180 and Q3 earnings confirm continued growth, and downgrade to bearish if the stock breaks below $166.17 on high volume or if revenue growth decelerates below 15%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on SPX Corporation's 12-month outlook, with a consensus price target around $257.36 and implied upside of +50.8% versus the current price.
Average Target
$257.36
0 analysts
Implied Upside
+50.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$215 - $310
Analyst target range
Coverage is robust with 13 analysts, and the consensus is emphatically bullish: the recommendation is a strong buy with a recommendation mean of 1.23 (where 1.0 is a strong buy), and the average target price of $263.31 implies approximately 52.1% upside from the current price of $173.09. This is a striking disconnect — analysts see the stock trading at a deep discount to fair value even as the market has driven it toward 52-week lows, and the consensus EPS estimate of $9.58 (range $9.25 to $9.87) and revenue estimate of $2.82 billion (range $2.75 billion to $2.89 billion) suggest analysts expect continued fundamental strength. The bullish consensus leans heavily on the view that the selloff is a sentiment-driven dislocation rather than a reflection of deteriorating business fundamentals.
The target range spans $215.00 to $310.00, a spread of $95.00 or roughly 44% of the average target, which signals meaningful disagreement about the company's trajectory. The high target of $310.00 implies roughly 79% upside and would require either multiple expansion toward the upper end of the historical PE band or accelerating growth beyond current estimates, while the low target of $215.00 still implies 24.2% upside and likely assumes more modest multiple recovery without a fundamental breakdown. Institutional ratings show a pattern of stability rather than deterioration: Truist Securities upgraded the stock from Hold to Buy on 2026-03-27 and has reiterated Buy four times since, while JP Morgan, Wells Fargo, and Oppenheimer have maintained Overweight/Outperform ratings through 2026 — no downgrades appear in the recent ratings history, reinforcing that the analyst community views the price weakness as an opportunity rather than a warning.
Bulls vs Bears: SPXC Investment Factors
The bull case rests on strong fundamental momentum — 22.9% revenue growth, expanding margins, and a conservative balance sheet — combined with an undemanding forward PE of 17.84x and a 52% analyst target upside. The bear case centers on the stock's severe technical breakdown, trading near 52-week lows with negative momentum and relative strength, suggesting the market is pricing in forward deceleration or cyclical concerns. The most important tension is whether the selloff is a sentiment-driven dislocation or a rational discounting of future headwinds; the resolution hinges on whether Q3 results confirm continued revenue acceleration and margin expansion. Currently, the bear evidence is stronger on price action and momentum, but the bull evidence is stronger on fundamentals and valuation, creating a classic value-versus-momentum debate. The analyst community overwhelmingly sides with the bulls, but the market's persistent selling pressure indicates skepticism that may only be resolved by upcoming earnings.
Bullish
- Revenue growth accelerating at 22.9% YoY: Q2 2026 revenue of $679.0 million grew 22.9% year-over-year from $552.4 million, and sequentially accelerated from $566.8 million in Q1 2026. This is the strongest growth rate in recent quarters, signaling robust demand across both segments.
- Analyst consensus strong buy with 52% upside: 13 analysts rate the stock a strong buy with a mean recommendation of 1.23, and the average target price of $263.31 implies 52.1% upside from the current $173.09. The low target of $215 still implies 24.2% upside, indicating a wide margin of safety even in the most conservative analyst view.
- Forward PE of 17.84x is undemanding: While the trailing PE of 39.23x looks expensive, the forward PE of 17.84x based on consensus EPS of $9.58 is below the S&P 500's typical forward multiple. If earnings materialize, the stock is being valued more conservatively than its own history suggests.
- Profitability expanding with 40% gross margins: Q2 2026 gross margin held at 40.18% and operating margin expanded to 17.17% from 15.68% a year earlier, while net margin improved to 11.55% from 9.45%. This demonstrates pricing power and operating leverage despite input cost pressures.
Bearish
- Severe relative underperformance and downtrend: The stock is down 23.99% over three months and 14.84% YTD, massively underperforming the S&P 500's 3.34% and 12.86% gains respectively. Relative strength versus SPY is -27.34 percentage points over three months, indicating persistent distribution.
- Trading near 52-week low with weak momentum: At $173.09, the stock sits just 4.0% above its 52-week low of $166.17 and 31% below its 52-week high of $251.08. The 10.44% monthly decline and 1.99% single-day bounce on light volume of 607,501 shares show no evidence of capitulation or institutional accumulation.
- PEG ratio of 2.24 signals growth premium: Even after adjusting for growth, the PEG ratio of 2.24 suggests the stock is not cheap. The market is pricing in substantial earnings growth, leaving limited room for disappointment if execution falters.
- High beta amplifies downside risk: With a beta of 1.269, the stock is 27% more volatile than the market. In a risk-off environment or sector rotation away from industrials, this amplifies losses, as evidenced by the -31.19% maximum drawdown over the period.
SPXC Technical Analysis
SPX Technologies is in a sustained downtrend that has erased prior gains, with the stock down 7.80% over the past year and 14.84% year-to-date, a stark underperformance against the S&P 500's 15.01% one-year and 12.86% YTD advances. At a current price of $173.09, the stock sits at roughly 8.2% of its 52-week range (calculated as ($173.09 - $166.17) / ($251.08 - $166.17)), placing it just above the 52-week low of $166.17 and far below the 52-week high of $251.08 — a positioning that signals persistent distribution and momentum weakness rather than a healthy pullback within an uptrend. This near-low positioning means buyers are catching a falling knife rather than buying strength, and the burden of proof rests on the stock to establish a base before any trend reversal can be credibly claimed.
Short-term momentum is decisively negative and deteriorating: the stock is down 10.44% over the past month and 23.99% over three months, with the 3-month decline far exceeding the 1-year decline, indicating the selling pressure has accelerated rather than stabilized. Relative strength confirms the severity of the underperformance, with the stock lagging SPY by 11.03 percentage points over one month, 27.34 points over three months, and 22.81 points over one year — a pattern of consistent and widening divergence from the market. The most recent session did show a modest bounce, with the stock up 1.99% to $173.09 from a previous close of $169.71, but this single-day gain is dwarfed by the 10.44% monthly decline and does not yet constitute a momentum shift; volume of 607,501 shares provides no evidence of climactic capitulation or institutional accumulation.
Key technical levels are clearly defined: support rests at the 52-week low of $166.17, just 4.0% below the current price, while resistance is anchored at the 52-week high of $251.08, roughly 45% above. A breakdown below $166.17 would signal a fresh leg lower and likely trigger momentum-driven selling, whereas reclaiming even the $190-$200 zone would be a first step toward repairing the trend. The stock's beta of 1.269 means it is approximately 27% more volatile than the market, amplifying both downside risk in the current downtrend and upside potential in any recovery, and the maximum drawdown of -31.19% over the period underscores the materiality of drawdown risk for position sizing.
Beta
1.24
1.24x market volatility
Max Drawdown
-31.2%
Largest decline past year
52-Week Range
$166-$251
Price range past year
Annual Return
-9.4%
Cumulative gain past year
| Period | SPXC Return | S&P 500 |
|---|---|---|
| 1m | -13.1% | +0.9% |
| 3m | -21.2% | +3.4% |
| 6m | -21.0% | +14.4% |
| 1y | -9.4% | +16.2% |
| ytd | -16.1% | +14.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SPXC Fundamental Analysis
Revenue growth is the standout positive in an otherwise challenged stock story: Q2 2026 revenue of $679.0 million grew 22.9% year-over-year versus $552.4 million in Q2 2025, continuing a multi-quarter acceleration from $566.8 million in Q1 2026, $637.3 million in Q4 2025, and $592.8 million in Q3 2025. The sequential progression from Q1 to Q2 2026 (+$112.2 million) and the year-over-year comparison both point to robust demand, with the Detection and Measurement segment contributing $485.8 million in reported revenue. This growth trajectory stands in sharp contrast to the stock's 23.99% three-month decline, suggesting either that the market is discounting future deceleration or that the selloff is disconnected from reported operating performance.
Profitability is solid and improving: Q2 2026 net income of $78.4 million on $679.0 million of revenue produced a net margin of 11.55%, up from 9.45% in Q2 2025, while gross margin held steady at 40.18% versus 41.44% a year earlier. Operating income of $116.6 million equates to a 17.17% operating margin, a meaningful expansion from 15.68% in Q2 2025, and EBITDA of $146.7 million represents a 21.61% EBITDA margin. The company is comfortably profitable with no loss-narrowing narrative required, and the margin profile — gross margins above 40% and operating margins in the mid-to-high teens — is consistent with a differentiated engineered-products manufacturer rather than a commodity industrial.
Balance sheet and cash flow metrics are healthy: debt-to-equity of 0.224 is conservative, the current ratio of 2.48 indicates ample liquidity, and trailing free cash flow of $303.4 million against a market cap of $9.57 billion implies a free cash flow yield of approximately 3.2%. Q2 2026 free cash flow was $68.5 million on operating cash flow of $89.6 million, though capital expenditures of $21.1 million and a $34.1 million working capital drag (including a $52.5 million receivables build) absorbed cash. ROE of 10.91% and ROA of 6.76% are respectable but not exceptional, and the Q1 2026 acquisition-related outflow of $439.6 million plus $172.2 million of debt repayment shows the company is actively deploying capital — funded internally and through financing — rather than relying on equity issuance, with no dividend or buyback program currently in place.
Quarterly Revenue
$679000000.0B
2026-06
Revenue YoY Growth
+22.9%
YoY Comparison
Gross Margin
40.2%
Latest Quarter
Free Cash Flow
$303400000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SPXC Overvalued?
Because SPX Technologies is profitable — Q2 2026 net income of $78.4 million and trailing EPS of $0.0255 (reflecting the quarterly figure) — the PE ratio is the appropriate primary metric, and the trailing PE of 39.23x stands in sharp contrast to the forward PE of 17.84x. This enormous gap implies the market expects earnings to more than double, consistent with the analyst consensus EPS estimate of $9.58 for the forward period versus the trailing run-rate, and it means the stock's valuation case rests almost entirely on forward execution rather than trailing results. The PEG ratio of 2.24 suggests that even after accounting for growth, the stock is not cheap on a growth-adjusted basis.
Relative to the broader market and sector context, the stock's PS ratio of 4.22 and EV/EBITDA of 20.02x represent a premium multiple for an industrial manufacturer, though the PB ratio of 4.28 and PCF ratio of 28.71 are less extreme. The forward PE of 17.84x is actually below the S&P 500's typical forward multiple, which creates a paradox: on trailing numbers the stock looks expensive at 39.23x, but on forward numbers it looks reasonably valued at 17.84x. The 40.5% gross margin and 15.5% operating margin support a premium to commodity industrials, but the 2.24 PEG ratio suggests the market is already pricing in substantial growth, leaving limited room for disappointment.
Historical context is instructive: the stock's PE ratio has ranged from roughly 19.2x (Q1 2023) to over 41.7x (Q1 2026), and the current trailing PE of 39.23x sits near the upper end of that band, while the PS ratio of 4.22 is well below the 17.10x recorded in the Q2 2026 historical ratios data (which appears to reflect a different share count basis). The forward PE of 17.84x is near the low end of the historical range, implying that if earnings materialize as expected, the stock is being valued more conservatively than its own history would suggest — a setup that favors bulls if execution continues, but one that offers little cushion if growth stalls.
PE
39.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 19x~50x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are moderate but notable. The company carries debt-to-equity of 0.224, which is conservative, but the Q1 2026 acquisition-related outflow of $439.6 million and $172.2 million of debt repayment show active capital deployment that could strain liquidity if cash flow generation slows. Free cash flow of $303.4 million TTM is healthy, but Q2 2026 free cash flow of $68.5 million was dampened by a $34.1 million working capital drag, including a $52.5 million receivables build, which may indicate loosening credit terms or slower collections. Revenue is concentrated in the HVAC segment, which generates the majority of revenue, and geographically in the United States, exposing the company to U.S. construction and industrial cycles. Gross margin has remained stable around 40%, but any input cost inflation or pricing pressure could compress margins, especially given the 2.24 PEG ratio that leaves little room for error.
Market and competitive risks are significant given the stock's recent underperformance. The stock trades at a trailing PE of 39.23x, near the upper end of its historical range of 19.2x to 41.7x, and a PS ratio of 4.22, which is a premium for an industrial manufacturer. If the market continues to de-rate growth stocks or if sector rotation away from industrials accelerates, the multiple could compress further. The beta of 1.269 means the stock is 27% more volatile than the market, amplifying downside in risk-off environments. Competitive threats in HVAC and detection technologies could pressure pricing and market share, though no specific news highlights this. The lack of recent news makes it difficult to assess emerging threats, but the stock's 27.34 percentage point underperformance versus SPY over three months suggests the market is pricing in negative developments not yet reflected in reported financials.
The worst-case scenario involves a breakdown below the 52-week low of $166.17, which is just 4.0% below the current price. If Q3 earnings disappoint — for example, revenue growth decelerates below 15% or margins contract — the stock could quickly test and break that support, triggering momentum-driven selling. The analyst low target of $215 is above the current price, so it does not represent a downside scenario; instead, the 52-week low of $166.17 and the maximum drawdown of -31.19% provide a more realistic downside reference. From the current price of $173.09, a drop to the 52-week low represents a 4.0% loss, but a more severe scenario could see the stock fall to the $150-$160 range, implying a 7.5% to 13.3% decline, if forward earnings estimates are cut. In a worst-case recession, the stock could revisit its 2024 lows, potentially down 20-30% from current levels.
FAQ
The most severe risk is technical: the stock is down 23.99% over three months and trading near its 52-week low of $166.17, with a break below that level likely triggering momentum-driven selling. Financial risks include a working capital drag from a $52.5 million receivables build and acquisition integration risk from the $439.6 million Q1 2026 outflow. Competitive and market risks include a high beta of 1.269, which amplifies losses in a downturn, and a premium valuation (PS of 4.22) that could compress if growth slows. Company-specific risks include revenue concentration in the HVAC segment and U.S. markets, making it vulnerable to cyclical downturns in construction and industrial spending. Ranked by severity: technical breakdown, growth deceleration, multiple compression, and integration missteps.
The 12-month forecast has three scenarios: a base case (50% probability) with a target range of $215-$263, assuming revenue growth decelerates modestly to 15-20% and margins remain stable; a bull case (30% probability) targeting $263-$310, driven by continued 20%+ growth and multiple expansion toward the analyst high target; and a bear case (20% probability) targeting $150-$166, assuming a revenue growth slowdown below 10% and a break below the 52-week low. The most likely scenario is the base case, where the stock partially recovers toward the analyst average target of $263.31 as earnings materialize but multiple expansion is limited. The key assumption is that forward EPS of $9.58 is met, which would justify the current forward PE of 17.84x and provide a path to higher prices.
On a trailing basis, SPXC appears overvalued with a PE of 39.23x, near the high end of its historical range of 19.2x to 41.7x, and a PS ratio of 4.22, which is a premium for an industrial manufacturer. However, on a forward basis, the PE of 17.84x is below the S&P 500's typical forward multiple, suggesting the stock is undervalued if earnings estimates are achieved. The PEG ratio of 2.24 indicates that even after adjusting for growth, the stock is not cheap, implying the market is already pricing in substantial growth. The market appears to be paying a fair price for future growth, with limited margin of safety if execution falters. Relative to its own history, the forward PE is near the low end, which could attract value-oriented investors.
From a risk/reward perspective, SPXC offers a compelling upside of 52.1% to the average analyst target of $263.31, with even the low target implying 24.2% upside. The forward PE of 17.84x is undemanding if earnings estimates of $9.58 are met, and the company's 22.9% revenue growth and 40% gross margins demonstrate fundamental strength. However, the stock is in a severe downtrend, down 23.99% over three months and trading just 4% above its 52-week low, with a beta of 1.269 amplifying downside risk. The biggest downside risk is a break below $166.17, which could trigger further selling toward $150. For long-term investors with a high risk tolerance, the risk/reward is favorable, but short-term traders should wait for a base to form above $180 before entering.
SPXC is more suitable for long-term investment (minimum 2-3 years) given its growth stage, lack of dividend, and high volatility (beta of 1.269). The company is in an expansion phase, with revenue growing 22.9% YoY and margins improving, but earnings visibility is moderate due to cyclical end markets and acquisition integration. Short-term trading is risky because the stock is in a downtrend and could break below the 52-week low of $166.17, leading to further losses. Long-term investors can look through the current weakness, focusing on the 52.1% analyst target upside and the forward PE of 17.84x, which suggests the stock is undervalued relative to its growth prospects. A suggested minimum holding period is 2-3 years to allow for multiple recovery and earnings growth to materialize.